Reactions of cisplatin hydrolytes, cis-[Pt(15NH3)2(H2O) 2]2+, with N-acetyl-L-cysteine

The reaction of cis-[Pt(¹⁵NH₃)2(H₂O) ₂] ²⁺ (3) with N-acetylcysteine [H₃accys] was investigated in aqueous solution. In this reaction, the ammine in the platinum complex formed was liberated. A mono-dentate sulfur-boundplatinum(II) product cis-[Pt(¹⁵NH₃)₂(H₂O)(H2accys-S)]⁺ (7) and six-membered che-late ring complex cis-[Pt(¹⁵NH₃)₂ (Haccys-S,O)] (8) were formed in solution. The dinuclear sulfur-bridged complex 9, giving a broad peak in ¹⁵N NMR, was also observed, but only present in very tiny amounts. The mass spectrometry (ES-MS) was undertaken from this re action, and the product detected was only the dinuclear sulfur bridged platinum species and species related to it by ammine loss.     

HPLC Method for the Determination of the Purity of K[Pt(NH3)Cl3], a Precursor of the Platinum Complexes with Cytostatic Activity

K[Pt(NH₃)Cl₃], a valuable precursor for the preparation of platinum complexes with cytostatic activity, e.g. satraplatin, picoplatin, LA-12 and cycloplatam, is currently prepared from cis-[Pt(NH₃)₂Cl₂] or K₂[PtCl₄] and these are the usual impurities in the final product. A simple, selective and sensitive HPLC-UV analytical method for the determination of the purity of K[Pt(NH₃)Cl₃] and the quantification of the impurities has been developed and validated. The platinum complexes present in the final product were separated on a strong base ion exchange column by the gradient elution with detection at 213 nm. Intra-assay precisions for the platinum complexes respective to their ions ([PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂]) were between 0.1 and 2.0% (relative standard deviation); intermediate precisions were between 1.4 and 2.0% and accuracies were between 98.6 and 101.4%. Limits of detection of [PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂] were 6 µg · ml^?1, 13 mg · ml^?1 and 5 µg · ml^?1 respectively, limits of quantification of [PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂] were 51 µg · ml^?1, 55 mg · ml^?1 and 20 µg · ml^?1 respectively.     

Stereoisomeric Pt(IV) complexes with threonine

Stereoisomeric Pt(IV) complexes with threonine (ThrH = HOCH(CH₃)CH(NH₂)COOH, ??-amino-??-hydroxybutyric acid) were obtained. In the complexes trans-[Pt(S-ThrH)₂Cl₄] and trans-[Pt(R-ThrH)(S-ThrH)Cl₄], the ThrH molecules act as monodentate ligands coordinated through the NH₂ group. In the complexes cis- and trans-[Pt(S-Thr)₂Cl₂] and trans-[Pt(R-Thr)(S-Thr)Cl₂], the deprotonated ligands are coordinated in a bidentate fashion through the NH₂ and COO^?-groups (R,S is the absolute configuration of the asymmetric carbon atom). All the complexes were identified using elemental analysis, IR spectroscopy, and ¹⁹⁵Pt, ¹³C, and ¹H NMR spectroscopy. The complexes trans-[Pt(S-ThrH)₂Cl₄] · 3H₂O and cis-[Pt(S-Thr)₂Cl₂] · 2H₂O were additionally characterized by X-ray diffraction.     

Platinum(III) formation and stabilization as “platinum blues” with different types of ligands in the course of their interaction with PtCl4 2- and cis-Pt(NH3)2CI2

Studying the kinetics of PtCl₄ ^2- cis-[Pt(NH₃)₂(H₂O)₂]²⁺ and cis-Pt(NH₃)₂Cl₂ (cis-DDP) reactions with different types of ligands using spectrophotometric, Potentiometric and EPR methods, the conditions for Pt(III) formation as transient species and its further stabilization as “Platinum Blue” complexes were found. A general method for obtaining “Platinum Blue” species is suggested.     

Addition of protic molecules to coordinated 2-pyridinecarboxaldehyde in gold(III), palladium(II), and platinum(II) complexes

The reactions of Au^III, Pt^II and Pd^II complexes with 2-pyridinecarboxaldehyde (2CHO-py) have been examined in protic (H₂O, MeOH, EtOH) and aprotic (DMF, CH₂Cl₂) solvents. Compounds in which the pyridine ligand is N-coordinated, either in the original aldehydic form or in a new form derived from addition of one or two protic molecules, have been isolated, namely: [Au(2CHO-py · H₂O)Cl₃], [Au(2CHO-py · MeOH)Cl₃], [Au(2CHO-py · 2EtOH)Cl₃], cis-[Pt(2CHO-py)₂Cl₂], trans-[Pd(2CHO-py)₂Cl₂], trans-[Pt(dmso)(2CHO-py)Cl₂], [Pt{C₅H₄N-(CH₂SMe)}Cl(2CHO-py)](ClO₄), [Pt(terpy)(2CHOpy)](ClO₄)₂, [Pt(terpy)(2CHO-py · H₂O)](ClO₄)₂ (terpy = 2,2′:6′,2′′-terpyridine). ¹H-n.m.r. experiments show that the addition of the protic molecule(s) to the Pt^II and Pd^II complexes is reversible. The effects of the nature of the metal ion and the ancillary ligands as well as of the total charge of the complexes on the relative stability of the addition products are discussed. This revised version was published online in June 2006 with corrections to the Cover Date.     

Stereoisomeric complexes of Pt(II) with threonine and allothreonine

The paper describes the synthesis of geometrical isomers and diastereomers of Pt(II) bischelates with diastereomeric hydroxy-amino acids threonine (threo-α-amino-β-hydroxybutyric acid CH₃C*H(OH)C*H(NH₂)COOH=ThrH) and allothreonine (erythro-α-amino-β-hydroxybutyric acid=alloThrH) containing two asymmetric carbon atoms C*: cis-,trans-[Pt(S-Thr)₂], cis-,trans-[Pt(RThr)(S-Thr)], cis-,trans-[Pt(R-alloThr)(S-alloThr)] (where R and S are the absolute configurations of the asymmetric carbon atom bonded to the carboxyl group). ¹⁹⁵Pt NMR spectroscopy is used to investigate the successive phases of the synthesis of the stereoisomeric Pt(II) complexes with threonine. The synthesized complexes are studied by ¹H, ¹³C, ¹⁹⁵Pt NMR spectroscopy, IR spectroscopy, and single crystal XRD.     

On Mixed-Valence Dinuclear PtII,PtIII Nucleobase Complexes Derived from cis-Diamineplatinum(II): Effect of steric bulk of amine ligands on the Pt-oxidation state

A series of closely related dinuclear (head-head) Pt^II complexes of general composition cis-[a₂PtL₂Pta′₂]²⁺ with a,a′ = NH₃ or CH₃NH₂ and L = 1-methyluracilate-N3,O4 (1-MeU) or 1-methylthyminate-N3,O4 (1-MeT) has been prepared and the solution behavior toward Ce^IV oxidation studied. The X-ray crystal structure of a representative example cis-[(CH₃NH₂)₂Pt(1-MeU)₂Pt(CH₃NH₂)₂](ClO₄)₂ · 0.5 H₂O ( 1b ), has been determined: Monoclinic, space group P2₁/c, a = 11.907(7) Å, b = 19.087(14) Å, c = 12.525(7) Å, β = 90.49(4)°, Z = 4. Oxidation of these diplatinum(II) complexes ([Pt^2.0]₂) with Ce^IV in aqueous solution to the corresponding diplatinum(III) species ([Pt^3.0]₂) proceeds via tetranuclear [Pt^2.25]₄ or dinuclear [Pt^2.5]₂ mixed-valence state compounds, depending on the nature of the a′ ligands: with a′ = NH₃, blue green [Pt^2.25]₄ forms, whereas with a′ = CH₃NH₂, purple [Pt^2.5]₂ represents the intermediate. This difference is interpreted in terms of differences in bulk between NH₃ and CH₃NH₂ ligands trans to the O(4) positions of the bridging nucleobases which influence the ability of dinuclear species to associate via the O(4)₂ Pt a₂′ faces.     

Metal catalysed Brooke rearrangement of 3-Halo-1-(trimethylsilyl) propan-2-one (Halo = Cl or Br)

The complexes [IrH(CO)(PPh₃)₃], trans-[IrCI(CO)- (PPh₃)₂], [RhH(PPh₃)₄], [Pd(PPh₃)₄], [Pt(trans-stilbene)(PPh₃)₂] and [Pt(η³-CH₂-COCH₂)-(PPh₃)₂] catalyse the rearrangement of Me₃SiCH₂C(O)CH₂Cl to CH₂?C(OSiMe₃)-CH₂Cl.     

Platinum(II) Diaquadiammine Complexes. Stable Hydrolysis Products by DFT Quantum-Chemical Calculations

The most stable hydrolysis products of cis-[Pt(NH₃)₂(H₂O)₂]^{2 +} were revealed by means of DFT quantum-chemical calculations of this complex and its deprotonated forms with full geometry optimization. The resulting force fields and normal mode vibrations were used to calculate thermodynamic characteristics for possible hydrolysis stages and equilibrium constants for proton-transfer processes in the gas phase and in aqueous solutions. The hydroxo-bridged dimers [Pt(NH₃)₂(-OH)]₂ ^{2 +} with short Pt+++Pt distances are the hydrolysis products of platinum(II) cis-diaquadiamminates in the aqueous medium.     

2-(diphenylphosphinylmethoxy)aniline: Synthesis,vibrational spectra,and crystal structure

The synthesis, vibrational spectra, and X-ray diffraction analysis results for 2-(diphenylphosphinylmethoxy) aniline, 2-[(C₆H₅)₂P(O)OCH₂]C₆H₄NH₂(I), are described. The crystals are monoclinic: a = 18.4515(17) Å, b = 10.5421(12) Å, c = 17.897(2) Å, β = 104.479(8)°, V = 3370.7(6) ų, Z = 8, space group P2₁/c, R = 0.0546 for 1770 reflections with I > 2σ(I). The unit cell contains two crystallographically independent molecules Ia and Ib joined by an N-H …O hydrogen bond between a hydrogen atom of the amino group of aniline in molecule Ia (Ib) and the phosphoryl oxygen atom of molecule Ib (Ia) (O…H 2.18 and 2.19 Å, N…O, 2.979(5) and 3.000(5) Å; NHO angle, 154° and 157°).     

Analogues of Cis‐ and Transplatin with a Rich Solution Chemistry: cis‐[PtCl2(NH3)(1‐MeC‐N3)] and trans‐[PtI2(NH3)(1‐MeC‐N3)]

Mono(nucleobase) complexes of the general composition cis‐[PtCl₂(NH₃)L] with L=1‐methylcytosine, 1‐MeC ( 1 a ) and L=1‐ethyl‐5‐methylcytosine, as well as trans‐[PtX₂(NH₃)(1‐MeC)] with X=I ( 5 a ) and X=Br ( 5 b ) have been isolated and were characterized by X‐ray crystallography. The Pt coordination occurs through the N3 atom of the cytosine in all cases. The diaqua complexes of compounds 1 a and 5 a , cis‐[Pt(H₂O)₂(NH₃)(1‐MeC)]²⁺ and trans‐[Pt(H₂O)₂(NH₃)(1‐MeC)]²⁺, display a rich chemistry in aqueous solution, which is dominated by extensive condensation reactions leading to μ‐OH‐ and μ‐(1‐MeC^?‐N3,N4)‐bridged species and ready oxidation of Pt to mixed‐valence state complexes as well as diplatinum(III) compounds, one of which was characterized by X‐ray crystallography: h,t‐[{Pt(NH₃)₂(OH)(1‐MeC^?‐N3,N4)}₂](NO₃)₂ ? 2 [NH₄](NO₃) ? 2 H₂O. A combination of ¹H NMR spectroscopy and ESI mass spectrometry was applied to identify some of the various species present in solution and the gas phase, respectively. As it turned out, mass spectrometry did not permit an unambiguous assignment of the structures of +1 cations due to the possibilities of realizing multiple bridging patterns in isomeric species, the occurrence of different tautomers, and uncertainties regarding the Pt oxidation states. Additionally, compound 1 a was found to have selective and moderate antiproliferative activity for a human cervix cancer line (SISO) compared to six other human cancer cell lines.     

A new synthesis of platinum—carbon bonds

Syntheses of cis-[PtCl(CH₂COCH₃)(PEt₃)₂], cis-[PtCl(CH₂NO₂) (PEt₃)₂], and trans-[Pt(CCPh)₂ (PEt₃)₂] are described. The procedure involves reaction of cis-[PtCl₂(PEt₃)₂] with Ag₂O and acidic CH bonds to precipitate AgC1 and generate a PtC bond. The method may represent a new general route to platinum—carbon bonds.     

Kinetic characterization of the interactions of trans-dichloro-platinum(IV) anticancer prodrugs and a model compound with thiosulfate

Sodium thiosulfate has been utilized as a rescuing agent for relief of the toxic effects of cisplatin and carboplatin. In this work, we characterized the kinetics of reactions of the trans-dichloro-platinum(IV) complexes cis-[Pt(NH₃)₂Cl₄], ormaplatin [Pt(dach)Cl₄] and trans-[PtCl₂(CN)₄]^2? (anticancer prodrugs and a model compound) with thiosulfate at biologically important pH. An overall second-order rate law was established for the reduction of trans-[PtCl₂(CN)₄]^2? by thiosulfate, and varying the pH from 4.45 to 7.90 had virtually no influence on the reaction rate. In the reactions of thiosulfate with cis-[Pt(NH₃)₂Cl₄] and with [Pt(dach)Cl₄], the kinetic traces displayed a fast reduction step followed by a slow substitution involving the intermediate Pt(II) complexes. The reduction step also followed second-order kinetics. Reductions of cis-[Pt(NH₃)₂Cl₄] and [Pt(dach)Cl₄] by thiosulfate proceeded with similar rates, presumably due to their similar configurations, whereas the reduction of trans-[PtCl₂(CN)₄]^2? was about 1,000 times faster. A common reduction mechanism is suggested, and the transition state for the rate-determining step has been delineated. The activation parameters are consistent with transfer of Cl⁺ from the platinum(IV) center to the attacking thiosulfate in the rate-determining step.     

Hydrolysis of cis- and trans-Diammineplatinum(II) Complexes: Hydration, Equilibrium, and Kinetics Properties

We have used a combination of ultrasound and density techniques to measure the hydration parameters, apparent molar volume, and apparent molar adiabatic compressibility, of the antitumor drug cis-dichlorodiammineplatinum(II), cis-[Pt(NH₃)₂Cl₂], and its inactive isomer trans-dichlorodiammineplatinum(II), trans-[Pt(NH₃)₂Cl₂], in 10 mM NaNO₃, pH 5.6 at 37°C. The data have been interpreted in terms of the overall hydration of each isomer, the actual hydration contribution to the adiabatic compressibility, K _h, ranges from –56.4 × 10^–4 to –20.3 × 10^–4 cm³-mol^–1-bar^–1, and the volume contribution, V _h, ranges from –16.3 to –6.4 cm³-mol^–1. The negative signs of these hydration contributions indicate that the volume and compressibility of the water immobilized by the platinum complexes is smaller than the volume and compressibility of bulk water. The V _h and K _h parameters for all platinum complexes investigated are linearly dependent on the relative amount of hydrolyzed chlorides. The values of each parameter become more negative with increasing hydrolysis, and show that the degree of hydration increases. The similar dependence of the amount of hydrolyzed chloride ligands reveals similar hydration properties for these two complexes. Thus, the symmetry of the complexes, which is of crucial importance for anticancer activity, has no influence on their hydration properties. Under our experimental conditions, the equilibrium constants for the hydrolysis of cis-[Pt(NH₃)₂Cl₂] are K ₁ = 2.52 mM and K ₂ = 0.04 mM. The equilibrium constant for the first step of hydrolysis of trans-[Pt(NH₃)₂Cl₂] is 0.03 mM, while the second chloride ligand cannot be substituted by water, even in the irreversible reaction with AgNO₃. Furthermore, continuous measurements of the ultrasonic velocity during hydrolysis permits the accurate evaluation of the pseudo-first-order rate constant k ₁ for the hydrolysis of the first chloride ligand of cis-[Pt(NH₃)₂Cl₂], which is 16±1×10^–5 s^–1.     

Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells

Cisplatin analogues, cis-dichloro(ethylenediamine-N,N′-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N′-di-3-propanoic acid)platinum(II) (2), as well as trans-dichloro-(ethylenediamine-N,N′-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine -N,N′-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N′-diacetato)-platinum(IV) (5) and trans-dibromo(propylenediamine-N,N′-diacetato)platinum(IV) (6), -([Pt(H₂eddp)Cl₂], [Pt(Heddp)I], trans-[Pt(eddp)Cl₂], trans-[Pt(eddp)Br₂], trans-[Pt(pdda)Cl₂] and trans-[Pt(pdda)Br₂], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin.     

Diamminesilver(I) bis(2‐amino‐5‐nitrobenzoato‐κ2O1,O1′)silver(I): a two‐dimensional supramolecular sheet with a short intersheet distance containing a rare four‐coordinate planar silver(I) centre

The asymmetric unit of the title compound, [Ag(NH₃)₂][Ag(C₇H₅N₂O₄)₂], comprises half an [Ag(NH₃)₂]⁺ cation and half an [Ag(anbz)₂]⁻ anion (anbz is 2‐amino‐5‐nitrobenzoate). Both Ag^I ions are located on inversion centres. The cation has a linear coordination geometry with two symmetry‐related ammine ligands. The Ag^I cation in the anionic part shows a rare four‐coordinate planar geometry completed by two chelating symmetry‐related anbz ligands. Intra‐ and intermolecular N—H...O hydrogen bonds create a slightly undulating two‐dimensional supramolecular sheet. Adjacent sheets are only ca 3.3 Å apart. Ag...O, Ag...N and π–π stacking interactions consolidate the packing of the molecules in the solid state.     

Aqua substitution from mononuclear Pt(II) complexes with 2-(pyrazol-1-ylmethyl)quinoline non-leaving ligands

The rates of aqua substitution from [Pt{2-(pyrazol-1-ylmethyl)quinoline}(H₂O)₂](ClO₄)₂, [Pt(H₂Qn)], [Pt{2-(3,5-dimethylpyrazol-1-ylmethyl)quinoline}(H₂O)₂](ClO₄)₂, [Pt(dCH₃Qn)], [Pt{2-[(3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]quinoline}(H₂O)₂](ClO₄)₂, [Pt(dCF₃Qn)], and [Pt{2-[(3,5-bis(trifluoromethyl)pyrazol-1-ylmethyl]pyridine}(H₂O)₂](ClO₄)₂, [Pt(dCF₃Py)], with three sulfur donor nucleophiles were studied. The reactions were followed under pseudo-first-order conditions as a function of nucleophile concentration and temperature using a stopped-flow analyzer and UV/visible spectrophotometry. The substitution reactions proceeded sequentially. The second-order rate constants for substituting the aqua ligands in the first substitution step increased in the order Pt(dCH₃Qn) < Pt(dCF₃Qn) < Pt(H₂Qn) < Pt(dCF₃Py), while that of the second substitution step was Pt(dCH₃Qn) < Pt(dCF₃Qn) < Pt(dCF₃Py) < Pt(H₂Qn). The reactivity trends confirm that the quinoline substructure in the (pyrazolylmethyl)quinoline ligands acts as an apparent donor of electron density toward the metal center rather than being a π-acceptor. Measured pK_a values from spectrophotometric acid–base titrations were Pt(H₂Qn) (pK_a1 = 4.56; pK_a2 = 6.32), Pt(dCH₃Qn) (pK_a1 = 4.88; pK_a2 = 6.31), Pt(dCF₃Qn) (pK_a1 = 4.07; pK_a2 = 6.35), and Pt(dCF₃Py) (pK_a1 = 4.76; pK_a2 = 6.27). The activation parameters from the temperature dependence of the second-order rate constants support an associative mechanism of substitution.     

Stereoisomeric Pd(II) complexes with serine,threonine, and allothreonine

The paper describes methods for the synthesis and isolation of solid phases of the individual stereoisomeric Pd(II) bis(amino acid) complexes with serine (SerH = NH₂C*H(CH₂OH)COOH, α-amino-β-hydroxypropionic acid), threonine (ThrH CH₃C*H(OH)C*H(NH₂)COOH, threo-α-amino-β-hydroxybutyric acid), and allothreonine (alloThrH is erythro-α-amino-β-hydroxybutyric acid): cis-[Pd(S-Ser)2], trans-[Pd(R-Ser)(S-Ser)], cis-[Pd(S-Thr)₂], trans-[Pd(S-Thr)₂], trans-[Pd(R-Thr)(S-Thr)], and cis-[Pd(R-alloThr)(S-alloThr)] (R, S are the absolute configurations of the asymmetric C* atom connected to the NH₂ group). The synthesized compounds were characterized by elemental analysis, IR and NMR (¹H and ¹³C) data, and X-ray diffraction analysis.     

Synthesis and reactivity with M(II) (M=Co and Cu) chloride of 1-[(2-carboxyethyl)benzene]-3-[benzothiazole]triazene

Reaction of ethyl anthranilate, sodium nitrite, and 2-aminobenzothiazole produces a new triazenide compound, 1-[(2-carboxyethyl)benzene]-3-[benzothiazole]triazene (HL), which has been characterized by X-ray crystallography and NMR spectrum. In the presence of Et₃N, reaction of HL and CuCl₂?·?2H₂O or CoCl₂?·?6H₂O in THF/methanol affords a tetranuclear copper(II) complex [Cu₄L₄(µ-OMe)₄]?·?4THF (1) and a cobalt(III) complex [CoL′₃] (2) (L′ is 1-[benzothiazole] triazene ion), accompanied by C–N bond cleavage of HL. They are characterized by X-ray crystallography and magnetic susceptibility measurement. Magnetic studies indicate significant antiferromagnetic coupling between the copper(II) centers for 1. The value obtained for the coupling constant J is ?585?cm^?1.     

Syntheses and crystal structures of two novel Cu(II) and Co(II) complexes with 3-methyl-4-(p-bromophenyl)-5-(2-pyridyl)-1,2,4-triazole

A new ligand, 3-methyl-4-(p-bromophenyl)-5-(2-pyridyl)-1,2,4-triazole (L) and its complexes, trans-[CuL₂(ClO₄)₂] (1) and cis-[CoL₂(H₂O)₂](ClO₄)₂·H₂O·CH₃OH (2), have been synthesized and characterized by UV, IR, electrospray ionization mass spectrum, elemental analyses, and single-crystal X-ray diffraction methods. In the structure, two L ligands are stabilized by intermolecular π···π interactions between the triazole rings. In the complexes, each L ligand adopts a chelating bidentate mode through N atom of pyridyl group and one N atom of the triazole. Both complexes have a similar distorted octahedral [MN₄O₂] core (M = Cu²⁺ and Co²⁺) with two ClO₄ ⁻ ions in the trans position in 1 but two H₂O molecules in the cis arrangement in 2.